Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
MiMedx Group is a leading US-based regenerative medicine company. It develops and distributes innovative biopharmaceutical products derived from human amniotic tissue. The company focuses on solutions for wound healing, orthopedic surgery, and musculoskeletal conditions.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
MiMedx Group is scheduled to report its next quarterly earnings on 11/04/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
MiMedx Group last reported quarterly earnings on 7/29/2026 (Q2 2026). Earnings per share (EPS) came in at -0.10 USD.
Across its last 3 earnings reports, MiMedx Group stock moved by ±6% on average the following day. The largest reaction was +8.7% on 04/29/2026; 2 of 3 reactions were positive.
MiMedx Group has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.